Conmed (CNMD) Profit After Tax Growth (1y) (2011 - 2026)
Conmed (CNMD) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 4.70% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -27.13% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 51.30% |
| 10 | Conmed | 1.06 Bn | 1.03 Bn | 183.45 Mn | 129.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.09% |
| Dec 31, 2025 | -50.41% |
| Sep 30, 2025 | -94.16% |
| Jun 30, 2025 | -28.54% |
| Mar 31, 2025 | -69.37% |
| Dec 31, 2024 | 2.07% |
| Sep 30, 2024 | 209.30% |
| Jun 30, 2024 | 118.29% |
| Mar 31, 2024 | 983.51% |
| Dec 31, 2023 | 24.40% |
| Sep 30, 2023 | -65.68% |
| Jun 30, 2023 | 108.16% |
| Mar 31, 2023 | -87.85% |
| Dec 31, 2022 | 8.75% |
| Sep 30, 2022 | 208.74% |
| Jun 30, 2022 | -1,366.30% |
| Mar 31, 2022 | 51.88% |
| Dec 31, 2021 | 1.26% |
| Sep 30, 2021 | 118.22% |
| Jun 30, 2021 | 148.50% |